Search research articles
Contact Us
Filters
Showing results (31-40 of 101) with videos related to
Page
of 11
Sort By:
The American Journal of Cardiology
|
July 25, 2008
Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker
Marshall A Corson, Peter H Jones, Michael H Davidson
Journal of Clinical Lipidology
|
January 19, 2020
Authors' response to letter by Anagnostis and Stevenson, "Is there a role for menopausal hormone therapy in a woman with increased lipoprotein(a) concentrations?"
Don P Wilson, Peter H Jones, Terry A Jacobson, et al.
Cleveland Clinic Journal of Medicine
|
December 1, 2005
Safety of statins: effects on muscle and the liver
Abu R Vasudevan, Yasmin S Hamirani, Peter H Jones
Journal of Clinical Lipidology
|
December 3, 2010
Management of Lp(a)
W Virgil Brown, Christie M Ballantyne, Peter H Jones, et al.
Journal of Clinical Lipidology
|
February 5, 2011
A case report of myopathy from consumption of red yeast rice
Venkateshwar R Polsani, Peter H Jones, Christie M Ballantyne, et al.
Journal of the American College of Cardiology
|
November 2, 2019
"Zero": The New Superhero or Superhero in Training?
Vijay Nambi, Salim S Virani, Peter H Jones, et al.
American Heart Journal
|
January 22, 2005
Comparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemia
Peter H Jones, James M McKenney, Dean G Karalis, et al.
The American Journal of Cardiology
|
May 5, 2016
The Editor's Round Table: Current Perspectives on Triglycerides and Atherosclerosis
Vincent E Friedewald, Peter H Jones, Preston Mason, et al.
Journal of Clinical Lipidology
|
December 20, 2014
National Lipid Association Annual Summary of Clinical Lipidology 2015
Harold E Bays, Peter H Jones, W Virgil Brown, et al.
The American Journal of Medicine
|
July 26, 2017
Developing Optimized Treatment Plans for Patients with Dyslipidemia in the Era of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapeutics
James A Underberg, Michael J Blaha, Elizabeth J Jackson, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 101) with videos related to
Sort By:
Page
of 11
The American Journal of Cardiology
|
July 25, 2008
Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker
Marshall A Corson, Peter H Jones, Michael H Davidson
Journal of Clinical Lipidology
|
January 19, 2020
Authors' response to letter by Anagnostis and Stevenson, "Is there a role for menopausal hormone therapy in a woman with increased lipoprotein(a) concentrations?"
Don P Wilson, Peter H Jones, Terry A Jacobson, et al.
Cleveland Clinic Journal of Medicine
|
December 1, 2005
Safety of statins: effects on muscle and the liver
Abu R Vasudevan, Yasmin S Hamirani, Peter H Jones
Journal of Clinical Lipidology
|
December 3, 2010
Management of Lp(a)
W Virgil Brown, Christie M Ballantyne, Peter H Jones, et al.
Journal of Clinical Lipidology
|
February 5, 2011
A case report of myopathy from consumption of red yeast rice
Venkateshwar R Polsani, Peter H Jones, Christie M Ballantyne, et al.
Journal of the American College of Cardiology
|
November 2, 2019
"Zero": The New Superhero or Superhero in Training?
Vijay Nambi, Salim S Virani, Peter H Jones, et al.
American Heart Journal
|
January 22, 2005
Comparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemia
Peter H Jones, James M McKenney, Dean G Karalis, et al.
The American Journal of Cardiology
|
May 5, 2016
The Editor's Round Table: Current Perspectives on Triglycerides and Atherosclerosis
Vincent E Friedewald, Peter H Jones, Preston Mason, et al.
Journal of Clinical Lipidology
|
December 20, 2014
National Lipid Association Annual Summary of Clinical Lipidology 2015
Harold E Bays, Peter H Jones, W Virgil Brown, et al.
The American Journal of Medicine
|
July 26, 2017
Developing Optimized Treatment Plans for Patients with Dyslipidemia in the Era of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapeutics
James A Underberg, Michael J Blaha, Elizabeth J Jackson, et al.
Page
of 11